Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 20:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.3
- Combined market value
- SEK 91.05T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | SEK 309.1B | SEK 2,044.61 | 4.51% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | SEK 181B | SEK 6,469.26 | 1.91% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | SEK 2.11T | SEK 1,699.90 | 1.33% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.1 | SEK 505.8B | SEK 1,793.70 | 0.79% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | SEK 62.9B | SEK 445.14 | 1.28% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.5 | SEK 243.1B | SEK 5,708.83 | 3.01% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.6 | SEK 107.8B | SEK 945.89 | 3.16% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | SEK 5.11T | SEK 2,890.84 | 0.86% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | SEK 346B | SEK 17,394.42 | 1.79% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | SEK 322.3B | SEK 522.78 | 0.60% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.6 | SEK 465.8B | SEK 4,078.11 | 0.89% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | SEK 128.6B | SEK 3,262.77 | 0.18% down | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.0 | SEK 282.4B | SEK 4,053.48 | 1.60% down | 57% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.3 | SEK 72.3B | SEK 660.57 | 4.43% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | SEK 116.5B | SEK 741.30 | 0.06% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.5 | SEK 47.3B | SEK 492.95 | 3.76% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | SEK 93.8B | SEK 4,039.26 | 0.48% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.9 | SEK 610.1B | SEK 1,061.00 | 1.11% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.9 | SEK 75B | SEK 954.22 | 1.53% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | SEK 1.35T | SEK 5,314.77 | 2.83% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.2 | SEK 72.8B | SEK 1,384.19 | 1.32% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.7 | SEK 76.9B | SEK 584.82 | 0.51% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | SEK 63.7B | SEK 975.46 | 3.44% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | SEK 554.6B | SEK 7,039.70 | 1.15% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.0 | SEK 1.44T | SEK 4,156.51 | 3.15% down | 24% down | ||
| 126 | BillionToOneBLLN · Health Care | 14.2 | SEK 44.1B | SEK 922.08 | 1.20% down | 4% down | ||
| 127 | argenxARGX · Health Care | 14.3 | SEK 605.2B | SEK 9,623.30 | 0.28% up | 2% up | ||
| 128 | RepligenRGEN · Health Care | 14.8 | SEK 111.1B | SEK 1,738.74 | 1.23% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 15.9 | SEK 100B | SEK 661.74 | 1.84% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | SEK 397B | SEK 690.44 | 1.38% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.4 | SEK 46.2B | SEK 285.63 | 1.56% down | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.3 | SEK 430B | SEK 2,965.47 | 0.47% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | SEK 12.28T | SEK 13,784.44 | 2.22% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.1 | SEK 201.1B | SEK 1,486.20 | 0.43% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.2 | SEK 77.7B | SEK 1,139.76 | 3.92% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.0 | SEK 171B | SEK 2,607.10 | 5.41% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | SEK 58.6B | SEK 2,930.14 | 3.79% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.3 | SEK 40B | SEK 455.23 | 2.70% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.1 | SEK 95.5B | SEK 3,222.09 | 0.22% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.8 | SEK 144B | SEK 2,433.16 | 2.39% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.4 | SEK 917.2B | SEK 4,667.10 | 1.79% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.3 | SEK 155.2B | SEK 796.88 | 0.19% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.1 | SEK 48.2B | SEK 1,071.75 | 2.96% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.5 | SEK 822.4B | SEK 2,032.48 | 1.30% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | SEK 82.6B | SEK 1,191.75 | 1.81% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.2 | SEK 322.6B | SEK 1,470.65 | 20.40% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.6 | SEK 71.2B | SEK 66.93 | 2.01% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.4 | SEK 73.1B | SEK 524.66 | 0.27% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 176 | SEK 82.4B | SEK 1,262.92 | 2.59% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 260 | SEK 104B | SEK 1,218.06 | 1.37% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1074 | SEK 38.4B | SEK 396.20 | 3.31% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1806 | SEK 74.4B | SEK 832.67 | 2.09% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2343 | SEK 48.6B | SEK 863.71 | 0.88% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3419 | SEK 287.9B | SEK 397.37 | 0.63% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1955 SEK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 20:57 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of SEK 91.05T as of 19 Nov 2026, 20:57 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.